Add like
Add dislike
Add to saved papers

Queen venom isosolenopsin A delivers rapid incapacitation of fire ant competitors.

Fire ant venom contains insecticidal alkaloids named 'solenopsins'. Whilst species-specific differences are reported, little attention has been given to caste-specific venom adaptations. The venom of fire ant queens has remained particularly poorly studied, though studies have shown it to be strikingly similar across different species, in being primarily composed of the alkaloid isosolenopsin A, regardless of the chemical configuration in workers. We predict that this is the evolutionary outcome of stabilising selection, implying that a shared mechanism is responsible for the conserved venom composition among fire ant queens. The present investigation tests whether venom plays a role in nest founding, when queens must succeed in isolation in the field against competitor species. Here, we report that fire ant queen venom and isosolenopsin A are faster to incapacitate alien ants than the venom of fire ant workers. Representative sympatric competitor ant species were selected and exposed on their heads to the venom of workers and queens of the invasive fire ant species Solenopsis invicta and S. geminata. Queen venom was found to incapacitate rival foragers quicker than worker venom. The effects were reproduced using synthetic solenopsins, establishing that solenopsin A analogues are particularly effective contact neurotoxins. Overall, the venom of S. invicta is more lethal than of S. geminata, regardless of the incapacitation speed. We believe these are fundamental aspects of the chemical ecology of the invasive ants which remain overlooked, and emphasise the need for further studies into the venom biology of founding queens.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app